TNF, JAK Inhibitors' CV Safety Compared in PsA, AxSpA
JAK inhibitors were not associated with higher risk of myocardial infarction or stroke and venous thromboembolism, compared with TNF-inhibitor users, in a small study.
Source: medscape.com
Stay updated with breaking news from Marketscan Database. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
JAK inhibitors were not associated with higher risk of myocardial infarction or stroke and venous thromboembolism, compared with TNF-inhibitor users, in a small study.